GRM1 Gene Spinocerebellar Ataxia Type 13 Autosomal Recessive NGS Genetic DNA Test
Understanding GRM1 Gene Spinocerebellar Ataxia Type 13
Spinocerebellar ataxia type 13 is a rare neurological disorder characterized by progressive impairment of coordination and balance due to mutations in the GRM1 gene. This autosomal recessive condition requires inheritance of two mutated copies of the gene – one from each parent – for symptoms to manifest. The GRM1 gene encodes metabotropic glutamate receptor 1, which plays a crucial role in cerebellar function and neuronal communication.
What This Test Detects
Our advanced NGS genetic DNA test specifically analyzes the GRM1 gene to identify pathogenic variants responsible for spinocerebellar ataxia type 13. The test examines:
- Point mutations and small insertions/deletions in the GRM1 gene
- Autosomal recessive inheritance patterns
- Pathogenic variants affecting glutamate receptor function
- Genetic markers associated with cerebellar degeneration
Who Should Consider This Test
This genetic test is recommended for individuals experiencing:
- Progressive coordination difficulties and balance problems
- Family history of spinocerebellar ataxia or similar neurological conditions
- Early-onset cerebellar symptoms in childhood or adolescence
- Unexplained gait abnormalities and motor coordination issues
- Speech difficulties related to cerebellar dysfunction
- Parents planning pregnancy with family history of neurological disorders
Key Benefits of Genetic Testing
- Early Diagnosis: Enables timely intervention and management strategies
- Family Planning: Provides crucial information for reproductive decisions
- Personalized Care: Guides appropriate neurological treatment approaches
- Genetic Counseling: Professional guidance for understanding inheritance risks
- Peace of Mind: Clarifies diagnosis and reduces diagnostic uncertainty
Understanding Your Test Results
Your genetic test results will be carefully interpreted by our expert team:
- Positive Result: Indicates presence of pathogenic GRM1 gene mutations confirming spinocerebellar ataxia type 13 diagnosis
- Negative Result: Suggests absence of tested mutations, though other genetic causes may need consideration
- Variant of Uncertain Significance: Requires further clinical correlation and family studies
- Carrier Status: Identifies individuals with one mutated copy who may pass the condition to offspring
Test Pricing Information
| Test Description | Price (USD) |
|---|---|
| GRM1 Gene Spinocerebellar Ataxia Type 13 Autosomal Recessive NGS Genetic DNA Test – Discount Price | $500 |
| GRM1 Gene Spinocerebellar Ataxia Type 13 Autosomal Recessive NGS Genetic DNA Test – Regular Price | $700 |
Test Specifications
- Turnaround Time: 3 to 4 Weeks
- Sample Type: Blood, Extracted DNA, or One Drop Blood on FTA Card
- Methodology: Next-Generation Sequencing (NGS) Technology
- Specialty: Neurology & Genetics
- Disease Category: Neurological Disorders
Pre-Test Requirements
Before testing, we provide:
- Comprehensive clinical history assessment
- Professional genetic counseling session
- Family pedigree chart development
- Detailed explanation of testing process and implications
Nationwide Accessibility
We have convenient testing locations across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many other cities. Our network ensures accessible genetic testing services for patients nationwide.
Take the Next Step Toward Clarity
Don’t let uncertainty about neurological symptoms affect your quality of life. Our GRM1 gene testing provides definitive answers and empowers you with knowledge for better health management. Contact our genetic specialists today to schedule your test and begin your journey toward accurate diagnosis and personalized care.
Call or WhatsApp us now at +1(267) 388-9828 to book your GRM1 Gene Spinocerebellar Ataxia Type 13 Autosomal Recessive NGS Genetic DNA Test and take control of your neurological health.
